These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29752723)

  • 1. Mimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer.
    La Manna S; Lee E; Ouzounova M; Di Natale C; Novellino E; Merlino A; Korkaya H; Marasco D
    Int J Cancer; 2018 Nov; 143(9):2177-2186. PubMed ID: 29752723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylated SOCS3 Mimetics Encapsulated into PLGA-NPs as Selective Inhibitors of JAK/STAT Pathway in TNBC Cells.
    La Manna S; Cugudda A; Mercurio FA; Leone M; Fortuna S; Di Natale C; Lagreca E; Netti PA; Panzetta V; Marasco D
    Int J Nanomedicine; 2024; 19():7237-7251. PubMed ID: 39050870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
    Li XD; Li XM; Gu JW; Sun XC
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway.
    Chen M; Zeng J; Chen S; Li J; Wu H; Dong X; Lei Y; Zhi X; Yao L
    Aging (Albany NY); 2020 Jun; 12(11):10896-10911. PubMed ID: 32516133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis.
    Chang R; Song L; Xu Y; Wu Y; Dai C; Wang X; Sun X; Hou Y; Li W; Zhan X; Zhan L
    Nat Commun; 2018 Aug; 9(1):3486. PubMed ID: 30154439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist.
    Waiboci LW; Ahmed CM; Mujtaba MG; Flowers LO; Martin JP; Haider MI; Johnson HM
    J Immunol; 2007 Apr; 178(8):5058-68. PubMed ID: 17404288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
    Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
    Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of SOCS3 overexpression in high glucose‑induced lung epithelial cell injury through the JAK2/STAT3 pathway.
    Duan WN; Xia ZY; Liu M; Sun Q; Lei SQ; Wu XJ; Meng QT; Leng Y
    Mol Med Rep; 2017 Sep; 16(3):2668-2674. PubMed ID: 28713982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of SOCS3 and STAT3 in bacterial infection and inflammatory diseases.
    Gao Y; Zhao H; Wang P; Wang J; Zou L
    Scand J Immunol; 2018 Dec; 88(6):e12727. PubMed ID: 30341772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhophilin-associated tail protein 1 promotes migration and metastasis in triple negative breast cancer via activation of RhoA.
    Liu Q; Huang X; Li Q; He L; Li S; Chen X; Ouyang Y; Wang X; Lin C
    FASEB J; 2020 Aug; 34(8):9959-9971. PubMed ID: 32427399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR-30c in breast cancer.
    Yen MC; Shih YC; Hsu YL; Lin ES; Lin YS; Tsai EM; Ho YW; Hou MF; Kuo PL
    Oncol Rep; 2016 Mar; 35(3):1356-64. PubMed ID: 26707189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hepatitis C virus (HCV) protein, p7, suppresses inflammatory responses to tumor necrosis factor (TNF)-α
    Convery O; Gargan S; Kickham M; Schroder M; O'Farrelly C; Stevenson NJ
    FASEB J; 2019 Aug; 33(8):8732-8744. PubMed ID: 31163989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
    Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
    Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
    Yu TJ; Liu YY; Li XG; Lian B; Lu XX; Jin X; Shao ZM; Hu X; Di GH; Jiang YZ
    Cancer Res; 2021 Nov; 81(21):5491-5505. PubMed ID: 34408002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation.
    Morelli M; Madonna S; Albanesi C
    Front Immunol; 2024; 15():1393799. PubMed ID: 38975347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
    Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF
    Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel small molecule STAT3 inhibitor SLSI-1216 suppresses proliferation and tumor growth of triple-negative breast cancer cells through apoptotic induction.
    Park SK; Byun WS; Lee S; Han YT; Jeong YS; Jang K; Chung SJ; Lee J; Suh YG; Lee SK
    Biochem Pharmacol; 2020 Aug; 178():114053. PubMed ID: 32450253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation.
    Boyle K; Zhang JG; Nicholson SE; Trounson E; Babon JJ; McManus EJ; Nicola NA; Robb L
    Cell Signal; 2009 Mar; 21(3):394-404. PubMed ID: 19056487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model.
    Kim G; Ouzounova M; Quraishi AA; Davis A; Tawakkol N; Clouthier SG; Malik F; Paulson AK; D'Angelo RC; Korkaya S; Baker TL; Esen ES; Prat A; Liu S; Kleer CG; Thomas DG; Wicha MS; Korkaya H
    Oncogene; 2015 Feb; 34(6):671-80. PubMed ID: 24531711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.